Company: BIAF
Filing Date: 2025-04-22
Form Type: 424B3
Source: 0001641172-25-005598
Chunk: 58

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-22
Form: 424B3
Chunk 58
---
 able to initiate or maintain similar efforts in
all jurisdictions in which we may wish to market our diagnostic tests and product candidates. Accordingly, our efforts to protect our
intellectual property rights in such countries may be inadequate, which may have an adverse effect on our ability to successfully commercialize
our diagnostic tests and product candidates in all of our expected significant foreign markets. If we or our licensors encounter difficulties
in protecting, or are otherwise precluded from effectively protecting, the intellectual property rights important for our business in
such jurisdictions, the value of these rights may be diminished, and we may face additional competition in those jurisdictions.

| 26 |

In some jurisdictions, including European countries,
compulsory licensing laws compel patent owners to grant licenses to third parties. In addition, some countries limit the enforceability
of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which
could materially diminish the value of such patent. If we or any of our licensors are forced to grant a license to third parties under
patents relevant to our business, or if we or our licensors are prevented from enforcing patent rights against third parties, our competitive
position may be substantially impaired in such jurisdictions.

If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest, and our business may be adversely affected.

Our current or future trademarks or trade names may
be challenged, infringed, circumvented, declared generic or descriptive, or determined to be infringing on other marks. We may not be
able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition
by potential partners or customers in our markets of interest. During trademark registration proceedings, we may receive rejections of
our applications by the USPTO or in other foreign jurisdictions.

Although we would be given an opportunity to respond
to those rejections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign
jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks.
Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. If we
are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively, and our business
may be adversely affected. We may license our trademarks and tradenames